Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity
Erstveröffentlichung
2011
Wissenschaftlicher Artikel
Published in
Blood ; 117 (2011), 8. - S. 2469-2475. - ISSN 0006-4971
Link to publication
https://dx.doi.org/10.1182/blood-2010-09-307280Institutions
UKU. Klinik für Innere Medizin IIISubject headings
[Free subject headings]: acute myeloid-leukemia | colony-stimulating factor | binding-protein-alpha | c/ebp-alpha | myelodysplastic syndromes | consolidation therapy | favorable prognosis | normal karyotype | younger adults | trial[DDC subject group]: DDC 610 / Medicine & health